ホーム › 腎臓がん（腎細胞がん） › フロリダ州
フロリダ州における腎臓がん（腎細胞がん）の臨床試験
フロリダ州内の拠点で、腎臓がん（腎細胞がん）に関する31件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- Research Site, Miami
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/05更新 · NCT05536141Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
- NEO-811 Florida Site, Miami
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07300241Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Mayo Clinic in Florida, Jacksonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06265285A Phase 1 Study of the Safety and Tolerability of CTX-10726
- Mayo Clinic Florida, Jacksonville
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07419841Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
- Morton Plant Hospital, Clearwater
- 他11件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #48, Celebration
- Exelixis Clinical Site #11, Gainesville
- Exelixis Clinical Site #78, Jacksonville
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07285044Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Holy Cross Hospital, Fort Lauderdale
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
- H. Lee Moffitt Cancer Center, Tampa
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07594106DESTINY-PANTUMOUR04
- Research Site, Coral Springs
- Research Site, St. Petersburg
- Research Site, West Palm Beach
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center, Tampa
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Local Institution - 0177, Miami
- Local Institution - 0126, Orlando
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07293351Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Sylvester Comprehensive Cancer Center - Miami, Miami
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05267626Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
- Mayo Clinic in Florida, Jacksonville
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05327686Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Mayo Clinic Pharmacy, Jacksonville
- Orlando Health Ambulatory Care Center, Orlando
- Orlando Health Cancer Institute, Orlando
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Memorial Healthcare System, Hollywood
- The Oncology Institute of Hope & Innovation, Lakeland
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- UF Health Cancer Institute - Gainesville, Gainesville
- Miami Cancer Institute, Miami
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06661720Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1/2相
16歳以上 · 全性別 · 2026/08/20更新 · NCT05269381Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Jacksonville
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT05433142Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Center, Orange City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT04198766A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center - McKinley Drive, Tampa
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/09更新 · NCT03972657KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- AdventHealth Celebration, Celebration
- Mayo Clinic Comprehensive Cancer Center, Jacksonville
- Florida Cancer Specialists, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT06026410A Study of VET3-TGI in Patients With Solid Tumors
- University of Miami, Miami
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/07更新 · NCT06444815Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Mayo Clinic in Florida, Jacksonville
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/12更新 · NCT06349642A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Mayo Clinic, Jacksonville
- Moffitt Cancer Center, Tampa
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/09更新 · NCT06682793Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- AdventHealth Altamonte, Altamonte Springs
- AdventHealth Celebration, Celebration
- AdventHealth Kissimmee, Kissimmee
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2025/09/09更新 · NCT04510597A Beta-only IL-2 ImmunoTherapY Study
- Boca Raton Regional Hospital, Boca Raton
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/07/09更新 · NCT05086692A Study of IBI363 in Subjects with Advanced Solid Malignancies
- Ocala Oncology Center, Ocala
- BRCR Medical Center, Plantation
被験者募集中第2相
18歳以上 · 全性別 · 2024/12/19更新 · NCT06281678A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/25更新 · NCT05824975Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Moffitt Cancer Center, Tampa
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/15更新 · NCT04787042ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。